{"id":4008,"date":"2020-12-11T10:34:37","date_gmt":"2020-12-11T10:34:37","guid":{"rendered":"https:\/\/www.sfj-pharma.com\/?page_id=4008"},"modified":"2022-04-07T07:15:34","modified_gmt":"2022-04-07T15:15:34","slug":"primary-investors","status":"publish","type":"page","link":"https:\/\/www.sfj-pharma.com\/primary-investors\/","title":{"rendered":"Primary investors"},"content":{"rendered":"

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” padding_top=”60″][vc_column width=”1\/12″][\/vc_column][vc_column width=”5\/6″][vc_column_text]<\/p>\n

Primary Investors<\/h1>\n

[\/vc_column_text][\/vc_column][vc_column width=”1\/12″][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” padding_top=”60″][vc_column width=”1\/12″][\/vc_column][vc_column width=”1\/4″][vc_single_image image=”1133″ img_size=”medium” onclick=”custom_link” img_link_target=”_blank” qode_css_animation=”” link=”https:\/\/www.blackstone.com”][vc_empty_space height=”20px”][vc_column_text]<\/p>\n

Over $800 Billion<\/h2>\n

Assets Under Management<\/strong><\/p>\n

[\/vc_column_text][\/vc_column][vc_column width=”7\/12″][vc_column_text css=”.vc_custom_1607711260077{padding-left: 30px !important;}”]<\/p>\n

Blackstone<\/strong><\/h3>\n

We partner with pharmaceutical, biotech and medical technology companies to address unmet medical needs and improve the quality of life of patients around the world.<\/p>\n

 <\/p>\n

Filling a Void<\/strong><\/p>\n

Blackstone Life Sciences (BXLS) fills a critical void in the industry. While life sciences is seeing unprecedented innovation driven by rapid advancements in science and technology, it often lacks the necessary funding to bring medicines and healthcare technologies to market. We work in partnership with the pharmaceutical, biotechnology and medical technology industries to help meet this need.[\/vc_column_text][\/vc_column][vc_column width=”1\/12″][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” padding_top=”60″ padding_bottom=”60″][vc_column width=”1\/12″][\/vc_column][vc_column width=”1\/4″][vc_single_image image=”1128″ img_size=”medium” onclick=”custom_link” img_link_target=”_blank” qode_css_animation=”” link=”https:\/\/www.abingworth.com”][vc_empty_space height=”20px”][vc_column_text]<\/p>\n

$2.5 Billion<\/h2>\n

Raised in Life Science Funds<\/strong><\/p>\n

[\/vc_column_text][\/vc_column][vc_column width=”7\/12″][vc_column_text css=”.vc_custom_1607711273805{padding-left: 30px !important;}”]<\/p>\n

Abingworth<\/strong><\/h3>\n

We are Abingworth, a transatlantic bioscience investment firm with a deep understanding of both the science and markets we invest in.<\/p>\n

For over 30 years, Abingworth has been working alongside entrepreneurs to develop their ideas into products that have a dramatic impact on health. With a broad transatlantic approach to backing innovation, we invest in drugs, devices and diagnostics from seed-stage start-ups to publicly traded companies.[\/vc_column_text][\/vc_column][vc_column width=”1\/12″][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” padding_top=”60″][vc_column width=”1\/12″][\/vc_column][vc_column width=”5\/6″][vc_column_text] Primary Investors [\/vc_column_text][\/vc_column][vc_column width=”1\/12″][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” padding_top=”60″][vc_column width=”1\/12″][\/vc_column][vc_column width=”1\/4″][vc_single_image image=”1133″ img_size=”medium” onclick=”custom_link” img_link_target=”_blank” qode_css_animation=”” link=”https:\/\/www.blackstone.com”][vc_empty_space height=”20px”][vc_column_text] Over $800 Billion Assets Under Management [\/vc_column_text][\/vc_column][vc_column width=”7\/12″][vc_column_text css=”.vc_custom_1607711260077{padding-left: 30px !important;}”]…<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full_width.php","meta":{"footnotes":""},"yoast_head":"\nPrimary investors - SFJ Pharmaceuticals<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sfj-pharma.com\/primary-investors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Primary investors - SFJ Pharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” padding_top=”60″][vc_column width=”1\/12″][\/vc_column][vc_column width=”5\/6″][vc_column_text] Primary Investors [\/vc_column_text][\/vc_column][vc_column width=”1\/12″][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” padding_top=”60″][vc_column width=”1\/12″][\/vc_column][vc_column width=”1\/4″][vc_single_image image=”1133″ img_size=”medium” onclick=”custom_link” img_link_target=”_blank” qode_css_animation=”” link=”https:\/\/www.blackstone.com”][vc_empty_space height=”20px”][vc_column_text] Over $800 Billion Assets Under Management [\/vc_column_text][\/vc_column][vc_column width=”7\/12″][vc_column_text css=”.vc_custom_1607711260077{padding-left: 30px !important;}”]...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sfj-pharma.com\/primary-investors\/\" \/>\n<meta property=\"og:site_name\" content=\"SFJ Pharmaceuticals\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-07T15:15:34+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sfj-pharma.com\/primary-investors\/\",\"url\":\"https:\/\/www.sfj-pharma.com\/primary-investors\/\",\"name\":\"Primary investors - SFJ Pharmaceuticals\",\"isPartOf\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/#website\"},\"datePublished\":\"2020-12-11T10:34:37+00:00\",\"dateModified\":\"2022-04-07T15:15:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/primary-investors\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sfj-pharma.com\/primary-investors\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sfj-pharma.com\/primary-investors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sfj-pharma.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Primary investors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#website\",\"url\":\"https:\/\/www.sfj-pharma.com\/\",\"name\":\"SFJ Pharmaceuticals\",\"description\":\"Resources for Accelerated Clinical Development\",\"publisher\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sfj-pharma.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#organization\",\"name\":\"SFJ Pharmaceuticals\",\"url\":\"https:\/\/www.sfj-pharma.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/secureservercdn.net\/198.71.233.213\/c59.835.myftpupload.com\/wp-content\/uploads\/2020\/12\/SFJ-Logo-Final-RGB.png?time=1666279552\",\"contentUrl\":\"https:\/\/secureservercdn.net\/198.71.233.213\/c59.835.myftpupload.com\/wp-content\/uploads\/2020\/12\/SFJ-Logo-Final-RGB.png?time=1666279552\",\"width\":750,\"height\":205,\"caption\":\"SFJ Pharmaceuticals\"},\"image\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Primary investors - SFJ Pharmaceuticals","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sfj-pharma.com\/primary-investors\/","og_locale":"en_US","og_type":"article","og_title":"Primary investors - SFJ Pharmaceuticals","og_description":"[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” padding_top=”60″][vc_column width=”1\/12″][\/vc_column][vc_column width=”5\/6″][vc_column_text] Primary Investors [\/vc_column_text][\/vc_column][vc_column width=”1\/12″][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” padding_top=”60″][vc_column width=”1\/12″][\/vc_column][vc_column width=”1\/4″][vc_single_image image=”1133″ img_size=”medium” onclick=”custom_link” img_link_target=”_blank” qode_css_animation=”” link=”https:\/\/www.blackstone.com”][vc_empty_space height=”20px”][vc_column_text] Over $800 Billion Assets Under Management [\/vc_column_text][\/vc_column][vc_column width=”7\/12″][vc_column_text css=”.vc_custom_1607711260077{padding-left: 30px !important;}”]...","og_url":"https:\/\/www.sfj-pharma.com\/primary-investors\/","og_site_name":"SFJ Pharmaceuticals","article_modified_time":"2022-04-07T15:15:34+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sfj-pharma.com\/primary-investors\/","url":"https:\/\/www.sfj-pharma.com\/primary-investors\/","name":"Primary investors - SFJ Pharmaceuticals","isPartOf":{"@id":"https:\/\/www.sfj-pharma.com\/#website"},"datePublished":"2020-12-11T10:34:37+00:00","dateModified":"2022-04-07T15:15:34+00:00","breadcrumb":{"@id":"https:\/\/www.sfj-pharma.com\/primary-investors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sfj-pharma.com\/primary-investors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sfj-pharma.com\/primary-investors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sfj-pharma.com\/"},{"@type":"ListItem","position":2,"name":"Primary investors"}]},{"@type":"WebSite","@id":"https:\/\/www.sfj-pharma.com\/#website","url":"https:\/\/www.sfj-pharma.com\/","name":"SFJ Pharmaceuticals","description":"Resources for Accelerated Clinical Development","publisher":{"@id":"https:\/\/www.sfj-pharma.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sfj-pharma.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.sfj-pharma.com\/#organization","name":"SFJ Pharmaceuticals","url":"https:\/\/www.sfj-pharma.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sfj-pharma.com\/#\/schema\/logo\/image\/","url":"https:\/\/secureservercdn.net\/198.71.233.213\/c59.835.myftpupload.com\/wp-content\/uploads\/2020\/12\/SFJ-Logo-Final-RGB.png?time=1666279552","contentUrl":"https:\/\/secureservercdn.net\/198.71.233.213\/c59.835.myftpupload.com\/wp-content\/uploads\/2020\/12\/SFJ-Logo-Final-RGB.png?time=1666279552","width":750,"height":205,"caption":"SFJ Pharmaceuticals"},"image":{"@id":"https:\/\/www.sfj-pharma.com\/#\/schema\/logo\/image\/"}}]}},"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"khateam","author_link":"https:\/\/www.sfj-pharma.com\/author\/khateam\/"},"rttpg_comment":0,"rttpg_category":null,"rttpg_excerpt":"[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” padding_top=”60″][vc_column width=”1\/12″][\/vc_column][vc_column width=”5\/6″][vc_column_text] Primary Investors [\/vc_column_text][\/vc_column][vc_column width=”1\/12″][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” padding_top=”60″][vc_column width=”1\/12″][\/vc_column][vc_column width=”1\/4″][vc_single_image image=”1133″ img_size=”medium” onclick=”custom_link” img_link_target=”_blank” qode_css_animation=”” link=”https:\/\/www.blackstone.com”][vc_empty_space height=”20px”][vc_column_text] Over $800 Billion Assets Under Management [\/vc_column_text][\/vc_column][vc_column width=”7\/12″][vc_column_text css=”.vc_custom_1607711260077{padding-left: 30px !important;}”]...","_links":{"self":[{"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/pages\/4008"}],"collection":[{"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/comments?post=4008"}],"version-history":[{"count":25,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/pages\/4008\/revisions"}],"predecessor-version":[{"id":11636,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/pages\/4008\/revisions\/11636"}],"wp:attachment":[{"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/media?parent=4008"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}